Zura Bio
ZURA
34 hedge funds and large institutions have $58.1M invested in Zura Bio in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
36% more funds holding
Funds holding: 25 → 34 (+9)
20% more capital invested
Capital invested by funds: $48.5M → $58.1M (+$9.59M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$4.43M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$3.83M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$2.02M |
| 4 |
Millennium Management
New York
|
+$1.8M |
| 5 |
Capstone Investment Advisors
New York
|
+$985K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BGIM
Boussard & Gavaudan Investment Management
London,
United Kingdom
|
-$3.69M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$2.54M |
| 3 |
OCAM
Owl Creek Asset Management
New York
|
-$1.48M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$197K |
ZURA Hedge Fund Activity: Q1 2022 in Review
34 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q1 2022, worth a combined $58.1M — up 20% from $48.5M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ZURA positions and 3 closed out — a net gain of 9 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $4.43M. The largest seller was Boussard & Gavaudan Investment Management, exiting entirely with an estimated $3.69M sold.
- 34 institutional investors held Zura Bio (ZURA) as of Q1 2022, up from 25 in Q4 2021.
- Funds reported $58.1M of Zura Bio stock for Q1 2022, up 20% quarter-over-quarter.
- 12 funds opened new Zura Bio positions in Q1 2022 and 3 closed out, a net change of +9 holders.
- The largest Zura Bio buyer in Q1 2022 was Shaolin Capital Management, an estimated $4.43M added.
- The largest Zura Bio seller in Q1 2022 was Boussard & Gavaudan Investment Management, an estimated $3.69M sold.
Based on aggregated 13F filings for Q1 2022.